Qualitative Effects of AEF0217 in Down Syndrome People
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aelis Farma
- Trial code
- NCT07413224
- Record updated
- 8 April 2026
- Original description
Following the AEF0217-102 trial (NCT05748405), which investigated the effects of AEF0217 versus placebo, participants with Down syndrome and their caregivers who took part in the trial are invited to share their perceptions of what they experienced or observed, in an exploratory manner.Read full original descriptionShow less
Qualitative Evaluation of Perceived Effects Elicited by AEF0217 in Individuals With Down Syndrome
Following the AEF0217-102 trial (NCT05748405), which investigated the effects of AEF0217 versus placebo, participants with Down syndrome and their caregivers who took part in the trial are invited to share their perceptions of what they experienced or observed, in an exploratory manner.
This qualitative study collects information through a specific questionnaire developed for this purpose.
Inclusion: Participants having completed the trial AEF0217-102; Being the caregiver of the participant; Provided written informed consent (or assent in case of individuals with Down syndrome with no capacity to legally sign the consent).
Exclusion: 1- Not wanting to provide a written informed consent.